Are women with PCOS more at risk for endometrial cancer? What approach for such patients?

##plugins.themes.themeTen.article.main##

Vladislava Valerievna Khalenko
Rosa Anna Guiglia
Marta Alioto

Keywords

Policystyc ovarian syndrome (PCOS), Endometrial cancer (EC), Endometrial hyperplasia, Confounding factors

Downloads

Download data is not yet available.
Abstract 0 |

References

1.Tanos P, Dimitriou S, Gullo G, Tanos V. Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review. Int J Mol Sci. 2022 Feb 28;23(5):2653. doi: 10.3390/ijms23052653.
2.Mutlu L, Manavella DD, Gullo G, McNamara B, Santin AD, Patrizio P. Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes. Cancers (Basel). 2022 Oct 22;14(21):5187. 
3.Gullo G, Carlomagno G, Unfer V, D'Anna R. Myo-inositol: from induction of ovulation to menopausal disorder management. Minerva Ginecol. 2015 Oct;67(5):485-486.
4.Bezerra Espinola MS, Laganà AS, Bilotta G, Gullo G, Aragona C, Unfer V. D-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases. Am J Case Rep. 2021 Oct 7;22:e932722. doi: 10.12659/AJCR.932722.
5.Prapas Y, Petousis S, Panagiotidis Y, et al. Injection of embryo culture supernatant to the endometrial cavity does not affect outcomes in IVF/ICSI or oocyte donation cycles: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):169-173. doi: 10.1016/j.ejogrb.2012.03.003.
6.Cavaliere AF, Perelli F, Zaami S, et al. Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification. Int J Mol Sci. 2021 Nov 12;22(22):12248. doi: 10.3390/ijms222212248.